Bharat Biotech's Covaxin Neutralises Multiple Coronavirus Variants: ICMR

Bharat Biotech's Covaxin Neutralises Multiple Coronavirus Variants: ICMR

Outlook

The Indian Council of Medical Research (ICMR) on Wednesday revealed that Bharat Biotech's Covid-19 vaccine, Covaxin, is effective against multiple strains of SARS-CoV-2, including the double mutant strain, that was recently discovered in Maharashtra.

So far, four major strains of coronavirus have been discovered—double mutant strain (B.1.617 variant), UK strain (B.1.1.7 Variant), South African strain (B.1.351 Variant) and the Brazilian strain (P.1 Variant).

"ICMR study shows Covaxin neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well," the ICMR tweeted.

Disclaimer: This is an automatically aggregated article/story by a computer program and has not been created or edited by Newsdig.in.

World COVID19 Meter

162817722

Cases

142520539

Recovered

3373003

Deaths
Last updated: GMT
Advt
Advt
Advt
sitemap Disclaimer
Newsdig.in 2019